| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
|
Hein, Rebecca
|
|
2013
|
138 |
2 |
p. 529-542
|
artikel
|
| 2 |
Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?
|
Bundred, Nigel J.
|
|
2011
|
138 |
2 |
p. 359-368
|
artikel
|
| 3 |
Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women
|
Lajin, Bassam
|
|
2013
|
138 |
2 |
p. 611-619
|
artikel
|
| 4 |
A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer
|
Kümler, Iben
|
|
2013
|
138 |
2 |
p. 347-358
|
artikel
|
| 5 |
A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase
|
Hou, Ningqi
|
|
2013
|
138 |
2 |
p. 633-641
|
artikel
|
| 6 |
αB-Crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation
|
Petrovic, Vladimir
|
|
2013
|
138 |
2 |
p. 415-425
|
artikel
|
| 7 |
Body size throughout the life course and mammographic density in Mexican women
|
Rice, Megan S.
|
|
2013
|
138 |
2 |
p. 601-610
|
artikel
|
| 8 |
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis
|
Rakovitch, Eileen
|
|
2013
|
138 |
2 |
p. 581-590
|
artikel
|
| 9 |
Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapy
|
Chia, Victoria M.
|
|
2013
|
138 |
2 |
p. 621-631
|
artikel
|
| 10 |
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant
|
Obazee, Ofure
|
|
2013
|
138 |
2 |
p. 543-548
|
artikel
|
| 11 |
Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response
|
Cintolo, Jessica Anna
|
|
2013
|
138 |
2 |
p. 331-346
|
artikel
|
| 12 |
Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome
|
Synnestvedt, M.
|
|
2013
|
138 |
2 |
p. 485-497
|
artikel
|
| 13 |
Earwax type and osmidrosis: prognostic factor for breast cancer?
|
Sun, Yang
|
|
2013
|
138 |
2 |
p. 651-653
|
artikel
|
| 14 |
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up
|
Rosell, Johan
|
|
2013
|
138 |
2 |
p. 467-473
|
artikel
|
| 15 |
Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort
|
Jeon, Ye Won
|
|
2013
|
138 |
2 |
p. 475-484
|
artikel
|
| 16 |
Isogenic human mammary epithelial cell lines: novel tools for target identification and validation
|
Ulbricht, Ulrike
|
|
2013
|
138 |
2 |
p. 437-456
|
artikel
|
| 17 |
Need for clarification of data in a recent meta-analysis about polymorphisms in the leptin receptor gene and risk of breast cancer
|
Peng, Qiliu
|
|
2013
|
138 |
2 |
p. 655-656
|
artikel
|
| 18 |
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
|
Martín, Miguel
|
|
2013
|
138 |
2 |
p. 457-466
|
artikel
|
| 19 |
PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy
|
Wander, Seth A.
|
|
2013
|
138 |
2 |
p. 369-381
|
artikel
|
| 20 |
Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women
|
Llanos, Adana A.
|
|
2013
|
138 |
2 |
p. 571-579
|
artikel
|
| 21 |
Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis
|
de Glas, N. A.
|
|
2013
|
138 |
2 |
p. 561-569
|
artikel
|
| 22 |
Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer
|
Callihan, Eryn B.
|
|
2013
|
138 |
2 |
p. 549-559
|
artikel
|
| 23 |
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer
|
Moreno-Aspitia, Alvaro
|
|
2013
|
138 |
2 |
p. 427-435
|
artikel
|
| 24 |
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
|
Bjarnadottir, Olöf
|
|
2013
|
138 |
2 |
p. 499-508
|
artikel
|
| 25 |
TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cells
|
Liu, Yu-Peng
|
|
2013
|
138 |
2 |
p. 383-393
|
artikel
|
| 26 |
The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse
|
Hartkopf, A. D.
|
|
2013
|
138 |
2 |
p. 509-517
|
artikel
|
| 27 |
The prognostic impact of age in patients with triple-negative breast cancer
|
Liedtke, Cornelia
|
|
2013
|
138 |
2 |
p. 591-599
|
artikel
|
| 28 |
The protective effect of intermittent calorie restriction on mammary tumorigenesis is not compromised by consumption of a high fat diet during refeeding
|
Rogozina, Olga P.
|
|
2013
|
138 |
2 |
p. 395-406
|
artikel
|
| 29 |
Too many statistical errors for meaningful interpretation
|
Stang, A.
|
|
2013
|
138 |
2 |
p. 643-650
|
artikel
|
| 30 |
Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer
|
Sonnenblick, Amir
|
|
2013
|
138 |
2 |
p. 407-413
|
artikel
|
| 31 |
Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis
|
Batina, Nataliya G.
|
|
2013
|
138 |
2 |
p. 519-528
|
artikel
|
Tijdschrift beschrijving